Articles From: Sierra Metals announces production results for the second quarter of 2014 to Canadian Solar to Showcase North American Product Offerings at Intersolar


VANCOUVER , July 8, 2014 /PRNewswire/ - Sierra Metals Inc .
Sign-up for Sierra Metals announces production results for the second quarter of 2014 investment picks
---Qualcomm Technologies VoLTE solution based on Qualcomm Snapdragon 800 Processor with Integrated Multimode VoLTE and IMS Solution ---
Sign-up for Qualcomm Announces First Large-Scale Commercial VoLTE Launch in Japan investment picks
Jones Energy, Inc. (NYSE: JONE) (“Jones Energy” or “the Company”) today provided an update on the Company’s 2014 leasing program.
Sign-up for Jones Energy, Inc. Provides Mid-Year Update on Leasing Program and Schedules 2014 Second Quarter Earnings Release and Conference Call investment picks
ZHUHAI, China , July 8, 2014 /PRNewswire/ -- Actions Semiconductor Co., Ltd.
Sign-up for Actions Semiconductor Revises Revenue Outlook for the Second Quarter of 2014 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G017907-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/7/7/11G017907/Balmoral_Resources_logo-91259228495.jpg VANCOUVER, BC--(Marketwired - July 08, 2014) - Balmoral Resources Ltd.
Sign-up for Balmoral Resumes Drilling of Martiniere Gold System, Detour Gold Trend Project, Quebec investment picks
ROCKVILLE, Md., July 8, 2014 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN) , today announced the execution of a royalty acquisition agreement ("Agreement") with HealthCare Royalty Partners ("HC Royalty"). Per the Agreement, HC Royalty will make a $30 million cash payment to Supernus in consideration for acquiring from Supernus certain royalty and milestone rights related to the commercialization of Orenitram™ (treprostinil) Extended-Release Tablets by Supernus' partner United Therapeutics Corporation.
Sign-up for Supernus to Receive $30 Million in Non-Dilutive Royalty Deal investment picks
HOUSTON , July 8, 2014 /PRNewswire/ -- PetroLogistics LP (NYSE: PDH) ("PetroLogistics") announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), in connection with the previously announced acquisition of PetroLogistics by Flint Hills Resources, LLC ("Flint Hills") expired at 11:59 P.M. (Eastern Time) on July 7 , 2014.
Sign-up for PetroLogistics LP Announces Expiration Of Hart-Scott-Rodino Waiting Period For Merger With Flint Hills Resources investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0956169001&sourceType=1 http://media3.marketwire.com/logos/20130113-cgi_logo_b.jpg LONDON, UNITED KINGDOM --
Sign-up for European Commission selects CGI to support the Galileo program's Commercial Service initiative investment picks
UTI campuses in Illinois and North Carolina are among only 22 ACCSC-accredited institutions to receive the prestigious School of Excellence Award SCOTTSDALE, Ariz.
Sign-up for Universal Technical Institute Named School of Excellence, Highest Institutional Achievement Award by Accrediting Commission of Career Schools and Colleges investment picks
RANCHO CORDOVA, Calif., July 8, 2014 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq:KOOL) , an autologous cell-based regenerative medicine company, announced today that it recently participated in a pre-submission IDE (Investigational Device Exemption) teleconference with the Food and Drug Administration's ("FDA") Center for Biologics Evaluation and Research to discuss the Company's proposed pivotal clinical trial design for the treatment of Critical Limb Ischemia ("CLI") using its CLIRST (Critical Limb Ischemia Rapid Stem cell Therapy) treatment protocol delivered via the Company's proprietary SURGWERKS-CLI kit.
Sign-up for CESCA Management Provides Regulatory Update on Its Proposed U.S. Pivotal Critical Limb Ischemia Clinical Trial investment picks
Customers who order using Domino's iPad® app could win free pizza for a year ANN ARBOR, Mich.
Sign-up for Domino's Pizza® Launches Sweepstakes in Celebration of New iPad® Ordering App investment picks
NEW YORK (MarketWatch) -- KLA-Tencor (KLAC) said it increased its stock buyback program by up to 13 million additional shares.
Sign-up for KLA-Tencor increases stock buyback, dividend investment picks
Accenture (NYSE: ACN) has introduced a new release of Accenture Duck Creek Policy designed to help property and casualty insurers streamline policy administration processes, more clearly define workflows and get products to market more quickly.
Sign-up for Accenture Introduces New Release of Duck Creek Policy Software for Property & Casualty Insurance Companies investment picks
http://media.marketwire.com/attachments/201108/10048_CobraLogo-Black.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1129155&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for Cobra Electronics Introduces Cobra AirWave Box; A Bluetooth-Enabled, Portable, Waterproof Audio Speaker investment picks
http://media.marketwire.com/attachments/201209/51143_calliduscloud_logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1129332&ProfileId=051205&sourceType=1 PLEASANTON, CA --
Sign-up for Mobinil Selects CallidusCloud's Commissions to Optimize Dealer Compensation investment picks
Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) today announced that it has been awarded several contracts by Spirit AeroSystems, Inc. (NYSE:SPR) to produce structural assemblies for the Boeing 737 MAX commercial jetliner.
Sign-up for Spirit Selects Ducommun for Boeing 737 MAX investment picks
NeuroMetrix, Inc. (Nasdaq: NURO) today announced that its wearable technology for treatment of chronic pain received 510(k) clearance (K140333) from the U.S. Food and Drug Administration (FDA) for over-the-counter use.
Sign-up for FDA Clears NeuroMetrix Wearable Technology for Over-the-Counter Use in Treatment of Chronic Pain investment picks
Moody’s Corporation (NYSE:MCO) (“Moody’s” or the “Company”) today announced that it priced an underwritten public offering of $450 million aggregate principal amount of 2.75% senior unsecured notes due 2019, and $300 million aggregate principal amount of 5.25% senior unsecured notes due 2044.
Sign-up for Moody's Corporation Prices Senior Unsecured Notes Offering investment picks
BATON ROUGE, La., July 8, 2014 (GLOBE NEWSWIRE) -- Amedisys, Inc. (Nasdaq:AMED) , one of America's leading healthcare at home companies, announced today that it has been advised by the staff of the Securities and Exchange Commission ("SEC") that the investigation by the SEC related to the Company's operations and participation in the Medicare program has been completed and that the staff does not intend to recommend any enforcement action by the SEC.
Sign-up for Amedisys Announces Completion of SEC Investigation investment picks
MCLEAN, Va., July 8, 2014 (GLOBE NEWSWIRE) -- Iridium Communications Inc. (Nasdaq:IRDM) and its prime contractor, Thales Alenia Space, announced an important milestone in the development of the new Iridium NEXT constellation by completing the first successful end-to-end test call using Iridium NEXT hardware.
Sign-up for First Successful Call Completed Over Iridium Next Hardware investment picks
Eagle Pharmaceuticals Inc. (Nasdaq:EGRX) (“Eagle” or “the Company”) announced today that the United States Food and Drug Administration (“FDA”) has granted orphan drug designation to bendamustine hydrochloride (“HCl”), a ready-to-dilute concentrate solution for injection that will be administered by infusion over 10 minutes after dilution in 50mL of sodium chloride (“saline”) or a saline / dextrose mixture, for the treatment of chronic lymphocytic leukemia (“CLL”) and indolent B-cell non-Hodgkin’s lymphoma (“NHL”). Pursuant to the orphan drug designation, Eagle is eligible to receive tax incentives and Prescription Drug User Fee Act (“PDUFA”) fee savings, and believes it may receive seven years of marketing exclusivity.
Sign-up for Eagle Pharmaceuticals Receives Orphan Drug Designation for Lower Volume, Shorter Infusion Time Bendamustine Hydrochloride Product for Chronic Lymphocytic Leukemia and Indolent B-Cell Non-Hodgkin’s Lymphoma investment picks
BRIDGEVILLE, Pa., July 8, 2014 (GLOBE NEWSWIRE) -- Universal Stainless & Alloy Products, Inc. (Nasdaq:USAP) announced today that Christopher M.
Sign-up for Universal Stainless Promotes Christopher Zimmer to Executive Vice President and Chief Commercial Officer investment picks
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that it will ring the Closing Bell at the NASDAQ MarketSite in Times Square, New York City, on Thursday, July 10, 2014, at 4:00 p.m. ET.
Sign-up for Verastem to Ring the NASDAQ Stock Market Closing Bell and Host Annual Research and Development Day on July 10, 2014 investment picks
Navigant (NYSE: NCI) announced today that it will report its financial results for the second quarter ended June 30, 2014 on Tuesday, July 29, 2014 before the market opens.
Sign-up for Navigant to Report Second Quarter 2014 Results on July 29, 2014 investment picks
Perion Codefuel, a division of Perion Network Ltd.
Sign-up for Perion Partners with CYREN to Enhance Browsing Safety for Its App Users investment picks
The Howard Hughes Corporation ® (NYSE: HHC) and Smith’s Food & Drug announced today plans for a 78,000 square-foot food and drug store in Holladay, UT.
Sign-up for The Howard Hughes Corporation® Announces Smith’s Food & Drug® as an Anchor for Cottonwood Redevelopment investment picks
Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) today announced the successful completion of an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) for CTP-499, its investigational therapy targeting diabetic nephropathy.
Sign-up for Concert Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for CTP-499 investment picks
Sunnova and Enphase Energy, Inc. (NASDAQ:ENPH) today announced their continued expansion by launching into the U.S. Virgin Islands.
Sign-up for Sunnova Expands with Enphase Energy to Become First Solar Service Provider in the U.S. Virgin Islands investment picks
GUELPH, Ontario , July 8, 2014 /PRNewswire/ -- Canadian Solar Inc. (the "Company", or "Canadian Solar") (NASDAQ: CSIQ) , one of the world's largest solar power companies, today announced that the Company is exhibiting at Intersolar North America 2014.
Sign-up for Canadian Solar to Showcase North American Product Offerings at Intersolar investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Sierra Metals announces production results for the second quarter of 2014 to Canadian Solar to Showcase North American Product Offerings at Intersolar
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices